Literature DB >> 26950030

Accurate measurement of female genital tract fluid dilution in cervicovaginal lavage samples.

Scott A Churchman1, John A Moss2, Marc M Baum3.   

Abstract

An ion chromatographic method with conductivity detection for the precise and accurate analysis of lithium ions in phosphate-buffered saline, used as a cervicovaginal lavage (CVL) fluid, was developed and validated. The lithium ion dilution factor during the CVL is used to calculate the volume of cervicovaginal fluid (CVF) collected. Initial CVL Li(+) concentrations of 1mM and 10mM were evaluated. The method is robust, practical, and afforded an accurate measurement (5% of the measurement, or better) at 24μL of vaginal fluid simulant collected per mL of CVL fluid, as low as 5μLmL(-1) using 10mM Li(+) with a measurement accuracy of 6.7%. Ion chromatograms of real-world CVL samples collected in vivo from common animal models (sheep and pig-tailed macaque) and a human volunteer demonstrate that the analysis is interference-free. The method is readily transferrable and should enable the accurate measurement of CVF volume collected during CVLs benefitting a broad range of research disciplines, including pharmacokinetic, pharmacodynamic, metabolomic, and microbiome studies.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cervicovaginal fluid dilution; Cervicovaginal lavage; Ion chromatography; Lithium

Mesh:

Year:  2016        PMID: 26950030      PMCID: PMC4808354          DOI: 10.1016/j.jchromb.2016.02.033

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  36 in total

Review 1.  A vaginal fluid simulant.

Authors:  D H Owen; D F Katz
Journal:  Contraception       Date:  1999-02       Impact factor: 3.375

2.  Estimating volume of cervicovaginal secretions in cervicovaginal lavage fluid collected for measurement of genital HIV-1 RNA levels in women.

Authors:  Caroline Mitchell; Kathleen Paul; Kathy Agnew; Reggie Gaussman; Robert W Coombs; Jane Hitti
Journal:  J Clin Microbiol       Date:  2010-11-24       Impact factor: 5.948

3.  Cytomegalovirus (CMV) shedding is highly correlated with markers of immunosuppression in CMV-seropositive women.

Authors:  Ashley L Schoenfisch; Sheila C Dollard; Minal Amin; Lytt I Gardner; Robert S Klein; Kenneth Mayer; Anne Rompalo; Jack D Sobel; Michael J Cannon
Journal:  J Med Microbiol       Date:  2011-03-10       Impact factor: 2.472

4.  Quantitative and qualitative correlates of cervicovaginal herpes simplex virus type 2 shedding among HIV-infected women in the Women's Interagency HIV Study.

Authors:  B Aumakhan; S J Gange; C Beyrer; C A Gaydos; H Minkoff; D J Merenstein; M H Cohen; K Anastos; R Greenblatt; M J Nowicki; T C Quinn
Journal:  Int J STD AIDS       Date:  2011-05       Impact factor: 1.359

5.  Vaginal nitric oxide in pregnant women with bacterial vaginosis.

Authors:  Mehmet R Genç; Mary L Delaney; Andrew B Onderdonk; Steven S Witkin
Journal:  Am J Reprod Immunol       Date:  2006-08       Impact factor: 3.886

6.  HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study.

Authors:  Murat Gök; Daniëlle A M Heideman; Folkert J van Kemenade; Johannes Berkhof; Lawrence Rozendaal; Johan W M Spruyt; Feja Voorhorst; Jeroen A M Beliën; Milena Babovic; Peter J F Snijders; Chris J L M Meijer
Journal:  BMJ       Date:  2010-03-11

7.  Use of acyclovir for suppression of human immunodeficiency virus infection is not associated with genotypic evidence of herpes simplex virus type 2 resistance to acyclovir: analysis of specimens from three phase III trials.

Authors:  Deborah Watson-Jones; Anna Wald; Connie Celum; Jairam Lingappa; Helen A Weiss; John Changalucha; Kathy Baisley; Clare Tanton; Richard J Hayes; Joshua O Marshak; Rula Green Gladden; David M Koelle
Journal:  J Clin Microbiol       Date:  2010-08-11       Impact factor: 5.948

8.  Comparison of cervicovaginal lavage, cervicovaginal lavage enriched with cervical swab, and vaginal tampon for the detection of HIV-1 RNA and HSV-2 DNA in genital secretions.

Authors:  Sinéad Delany; Raul Rosas; Nonkululeko Mlaba; Tim Clayton; Godspower Akpomiemie; Jérôme LeGoff; Alexio Capovilla; Laurent Bélec; Wendy Stevens; Philippe Mayaud
Journal:  J Acquir Immune Defic Syndr       Date:  2008-12-01       Impact factor: 3.731

9.  Bacterial vaginosis, not HIV, is primarily responsible for increased vaginal concentrations of proinflammatory cytokines.

Authors:  Caroline M Mitchell; Jennifer Balkus; Kathy J Agnew; Susan Cohn; Amneris Luque; Richard Lawler; Robert W Coombs; Jane E Hitti
Journal:  AIDS Res Hum Retroviruses       Date:  2008-05       Impact factor: 2.205

10.  Genital herpes evaluation by quantitative TaqMan PCR: correlating single detection and quantity of HSV-2 DNA in cervicovaginal lavage fluids with cross-sectional and longitudinal clinical data.

Authors:  Bulbulgul Aumakhan; Andrew Hardick; Thomas C Quinn; Oliver Laeyendecker; Stephen J Gange; Chris Beyrer; Christopher Cox; Kathryn Anastos; Mardge Cohen; Ruth M Greenblatt; Daniel J Merenstein; Howard Minkoff; Marek Nowicki; Charlotte A Gaydos
Journal:  Virol J       Date:  2010-11-18       Impact factor: 4.099

View more
  5 in total

1.  Surrogate post-coital testing for contraceptive efficacy against human sperm activity in the ovine vaginal model†.

Authors:  Yong Zhu; Jamal Saada; Shrestha Bhawana; Sam Lai; Paula Villarreal; Richard Pyles; Massoud Motamedi; Gracie Vargas; Tom Moench; Kathleen L Vincent
Journal:  Biol Reprod       Date:  2021-02-11       Impact factor: 4.285

2.  Evaluation of the Pig-Tailed Macaque (Macaca nemestrina) as a Model of Human Staphylococcus aureus Nasal Carriage.

Authors:  Amy L Cole; Yvonne Cosgrove Sweeney; Amanda G Lasseter; Justin M Gray; Ashley C Beavis; Christine F Chong; Safarali V Hajheidari; Alex Beyene; Dorothy L Patton; Alexander M Cole
Journal:  Infect Immun       Date:  2018-05-22       Impact factor: 3.441

3.  Combination Pod-Intravaginal Ring Delivers Antiretroviral Agents for HIV Prophylaxis: Pharmacokinetic Evaluation in an Ovine Model.

Authors:  John A Moss; Irina Butkyavichene; Scott A Churchman; Manjula Gunawardana; Rob Fanter; Christine S Miller; Flora Yang; Jeremiah T Easley; Mark A Marzinke; Craig W Hendrix; Thomas J Smith; Marc M Baum
Journal:  Antimicrob Agents Chemother       Date:  2016-05-23       Impact factor: 5.191

4.  Safety and pharmacokinetics of single, dual, and triple antiretroviral drug formulations delivered by pod-intravaginal rings designed for HIV-1 prevention: A Phase I trial.

Authors:  Kathleen L Vincent; John A Moss; Mark A Marzinke; Craig W Hendrix; Peter A Anton; Richard B Pyles; Kate M Guthrie; Lauren Dawson; Trevelyn J Olive; Irina Butkyavichene; Scott A Churchman; John M Cortez; Rob Fanter; Manjula Gunawardana; Christine S Miller; Flora Yang; Rochelle K Rosen; Sara E Vargas; Marc M Baum
Journal:  PLoS Med       Date:  2018-09-28       Impact factor: 11.069

5.  Fractional CO2 laser treatment effect on cervicovaginal lavage zinc and copper levels: a prospective cohort study.

Authors:  Attila G Sipos; Krisztina Pákozdy; Szilvia Jäger; Kindra Larson; Peter Takacs; Bence Kozma
Journal:  BMC Womens Health       Date:  2021-06-06       Impact factor: 2.809

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.